F Formiga1,2, X Vidal3,4, A Agustí3,4, D Chivite1,2, B Rosón1, J Barbé2,5,6, A López-Soto2,7, O H Torres2,8, A Fernández-Moyano2,9, J García2,10, N Ramírez-Duque2,11, A San José2,5,6. 1. Internal Medicine Service, Hospital Universitari de Bellvitge, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. 2. Multimorbidity and Elderly Patients Group of the Spanish Society of Internal Medicine, Barcelona, Spain. 3. Clinical Pharmacology Service, Fundació Institut Català de Farmacologia, Hospital Universitari Vall D'Hebron, Barcelona, Spain. 4. Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain. 5. Internal Medicine Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain. 6. Universitat Autònoma de Barcelona, Barcelona. 7. Internal Medicine Service, Hospital Clínic, Barcelona, Spain. 8. Internal Medicine Service, Hospital Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain. 9. Internal Medicine Service, Hospital San Juan De Dios del Aljarafe, Seville, Spain. 10. Internal Medicina Service, Hospital General Juan Ramón Jiménez, Huelva, Spain. 11. Internal Medicine Service, Hospital Universitario Virgen del Rocío, Seville, Spain.
Abstract
AIMS: To assess inappropriate prescribing in older people with diabetes mellitus during the month prior to a hospitalization, using tools on potentially inappropriate medicines (PIMs) and potential prescribing omissions (PPOs) and comparing inappropriate prescribing in patients with without diabetes. METHODS: In an observational, prospective multicentric study, we assessed inappropriate prescribing in 672 patients aged 75 years and older during hospital admission. The Beers, Screening Tool of Older Person's Prescriptions (STOPP) and Screening Tool to Alert Doctors to Right Treatment (START) criteria and Assessing Care of Vulnerable Elders (ACOVE-3) medicine quality indicators were used. We analysed demographic and clinical factors associated with inappropriate prescribing. RESULTS: Of 672 patients, 249 (mean age 82.4 years, 62.9% female) had a diagnosis of diabetes mellitus. The mean number of prescribing drugs per patient with diabetes was 12.6 (4.5) vs. 9.4 (4.3) in patients without diabetes (P < 0.001). Of those patients with diabetes, 74.2% used 10 or more medications; 54.5% of patients with diabetes had at least one Beers-listed PIM, 68.1% had at least one STOPP-listed PIM, 64.6% had at least one START-listed PPO and 62.8% had at least one ACOVE-3-listed PPO. Except for the Beers criteria, these prevalences were significantly higher in patients with diabetes than in those without. After excluding diabetes-related items from these tools, only STOPP-listed PIMs remained significantly higher among patients with diabetes (P = 0.04). CONCLUSIONS: Polypharmacy is common among older patients with diabetes mellitus. Inappropriate prescribing is higher in older patients with diabetes, even when diabetes-related treatment is excluded from the inappropriate prescribing evaluation.
AIMS: To assess inappropriate prescribing in older people with diabetes mellitus during the month prior to a hospitalization, using tools on potentially inappropriate medicines (PIMs) and potential prescribing omissions (PPOs) and comparing inappropriate prescribing in patients with without diabetes. METHODS: In an observational, prospective multicentric study, we assessed inappropriate prescribing in 672 patients aged 75 years and older during hospital admission. The Beers, Screening Tool of Older Person's Prescriptions (STOPP) and Screening Tool to Alert Doctors to Right Treatment (START) criteria and Assessing Care of Vulnerable Elders (ACOVE-3) medicine quality indicators were used. We analysed demographic and clinical factors associated with inappropriate prescribing. RESULTS: Of 672 patients, 249 (mean age 82.4 years, 62.9% female) had a diagnosis of diabetes mellitus. The mean number of prescribing drugs per patient with diabetes was 12.6 (4.5) vs. 9.4 (4.3) in patients without diabetes (P < 0.001). Of those patients with diabetes, 74.2% used 10 or more medications; 54.5% of patients with diabetes had at least one Beers-listed PIM, 68.1% had at least one STOPP-listed PIM, 64.6% had at least one START-listed PPO and 62.8% had at least one ACOVE-3-listed PPO. Except for the Beers criteria, these prevalences were significantly higher in patients with diabetes than in those without. After excluding diabetes-related items from these tools, only STOPP-listed PIMs remained significantly higher among patients with diabetes (P = 0.04). CONCLUSIONS: Polypharmacy is common among older patients with diabetes mellitus. Inappropriate prescribing is higher in older patients with diabetes, even when diabetes-related treatment is excluded from the inappropriate prescribing evaluation.
Authors: Seth A Margolis; Malka Zughaft Sears; Lori A Daiello; Carly Solon; Luba Nakhutina; Claire J Hoogendoorn; Jeffrey S Gonzalez Journal: Int J Geriatr Psychiatry Date: 2019-07-22 Impact factor: 3.485
Authors: Labib Al-Musawe; Carla Torre; Jose Pedro Guerreiro; Antonio Teixeira Rodrigues; Joao Filipe Raposo; Helder Mota-Filipe; Ana Paula Martins Journal: Pharmacol Res Perspect Date: 2020-08
Authors: Antonio Nuñez-Montenegro; Alonso Montiel-Luque; Esther Martin-Aurioles; Felicisima Garcia-Dillana; Monica Krag-Jiménez; Jose A González-Correa Journal: J Clin Med Date: 2019-03-04 Impact factor: 4.241
Authors: Huberta E Hart; Kim Ditzel; Guy E Rutten; Esther de Groot; Samuel Seidu; Kamlesh Khunti; Rimke C Vos Journal: Patient Prefer Adherence Date: 2019-10-18 Impact factor: 2.711
Authors: Jaime Sanz-Cánovas; Almudena López-Sampalo; Lidia Cobos-Palacios; Michele Ricci; Halbert Hernández-Negrín; Juan José Mancebo-Sevilla; Elena Álvarez-Recio; María Dolores López-Carmona; Luis Miguel Pérez-Belmonte; Ricardo Gómez-Huelgas; Maria Rosa Bernal-López Journal: Int J Environ Res Public Health Date: 2022-07-16 Impact factor: 4.614